EMCUREPharmaceuticals
Emcure Pharmaceuticals Ltd — Quarterly Results & Earnings
₹1595.50
+4.14%
Profit Growth YoY25.13%Latest quarter
Sales Growth YoY13.38%Latest quarter
Sales CAGR 5Y9.36%5 year compound
Profit CAGR 5Y36.18%5 year compound
📋
Quarterly Performance
YoY Profit Growth+25.13%
🔥 Exceptional growth
YoY Sales Growth+13.38%
✅ Strong growth
OPM 5Y Average
20.45%Operating profit margin
EPS Growth 5Y
34.92%Interest Coverage
9.74Higher = safer debt servicing
ROE
18.51%ROCE
20.72%💡
Growth Analysis
Emcure Pharmaceuticals Ltd reported YoY profit growth of 25.13% and revenue growth of 13.38% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 9.36% and profits at 36.18% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Emcure Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.